NCT07494812 Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials
| NCT ID | NCT07494812 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas Southwestern Medical Center |
| Condition | NPH (Normal Pressure Hydrocephalus) |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2026-05-14 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2026-05-14 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The intellidrop device is an FDA-approved system that automates safe, small volume of cerebral spinal fluid drainage with continuous pressure monitoring, reducing nursing workload and human error while improving patient mobility and comfort
Eligibility Criteria
Inclusion Criteria: * All patients will be adults aged 60 years or older with suspected iNPH who are being admitted to the hospital for the purpose of an LDT specifically to evaluate for benefit from shunt placement. Exclusion Criteria: * Patients who are under 18 years of age, pregnant, or are currently incarcerated will be excluded from participating in this study.
Contact & Investigator
DaiWai Olson, PhD, RN, CCRN, FNCS
STUDY DIRECTOR
University of Texas
Frequently Asked Questions
Who can join the NCT07494812 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 99 Years, studying NPH (Normal Pressure Hydrocephalus). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07494812 currently recruiting?
Yes, NCT07494812 is actively recruiting participants. Contact the research team at padraig.osuilleabhain@utsouthwestern.edu for enrollment information.
Where is the NCT07494812 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT07494812 clinical trial?
NCT07494812 is sponsored by University of Texas Southwestern Medical Center. The principal investigator is DaiWai Olson, PhD, RN, CCRN, FNCS at University of Texas. The trial plans to enroll 10 participants.